Onartuzumab Biosimilar - Research Grade

Human

MET

5mg/ml

Human Fab - G1 - kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects MET

Blue ice

The hepatocyte growth factor receptor MET drives invasive growth and is a frequent contributor to therapy resistance in solid-tumour research. This monovalent Fab reagent is an unconjugated, non-therapeutic analog of onartuzumab directed against MET, supplied for research use only (RUO). It is produced to in vivo standards, carries low endotoxin, and is available in scalable milligram (mg) to gram (g) quantities for heavy-usage and high-throughput laboratories. Researchers apply it in functional assays, receptor-blockade and downstream-signalling studies, defined controls, and in vivo tumour models that benefit from a monovalent, reproducible reagent format.

MetMAb,OA-5D5,OA5D5,PRO 143966;met proto-oncogene, hepatocyte growth factor (HGF) receptor, HGFR, scatter factor (SF) receptor, HGF/SF receptor, receptor tyrosine-protein kinase c-met, papillary renal cell carcinoma 2, RCCP2

P08581

ICH3002

https://www.imgt.org/mAb-DB/